Serum lipids and lipoproteins in chinese men and women

Circulation

Volumn 125, Issue 18, 2012, Pages 2212-2221

  Yang, Wenying ^a   Xiao, Jianzhong ^a   Yang, Zhaojun ^a   Ji, Linong ^b   Jia, Weiping ^c   Weng, Jianping ^d   Lu, Juming ^e   Shan, Zhongyan ^f   Liu, Jie ^g   Tian, Haoming ^h   Ji, Qiuhe ⁱ   Zhu, Dalong ^j   Ge, Jiapu ^k   Lin, Lixiang ^l   Chen, Li ^m   Guo, Xiaohui ⁿ   Zhao, Zhigang ^o   Li, Qiang ^p   Zhou, Zhiguang ^q   Shan, Guangliang ^r   He, Jiang ^s   more..

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^d THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g Shanxi Province People's Hospital   (China)

^h SICHUAN UNIVERSITY   (China)

ⁱ FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^j THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^k Xinjiang Uygur Autonomous Region's Hospital   (China)

^l FUJIAN PROVINCIAL HOSPITAL   (China)

^m SHANDONG UNIVERSITY   (China)

ⁿ PEKING UNIVERSITY FIRST HOSPITAL   (China)

^o HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^p THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^q CENTRAL SOUTH UNIVERSITY   (China)

^r PEKING UNION MEDICAL COLLEGE   (China)

^s TULANE UNIVERSITY   (United States)

more..

Author keywords

China; Cross sectional studies; Lipids; Lipoproteins; Prevalence

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; STANDARDIZATION; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 84860762054     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.065904     Document Type: Article

References (30)

1. Zhai F, Wang H, Du S, He Y, Wang Z, Ge K, Popkin BM. Prospective study on nutrition transition in China. Nutr Rev. 2009;67(suppl 1): S56-S61.
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-1134. (Pubitemid 41317435)
3. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000;284:311-318. (Pubitemid 30469857)
4. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA. 1999; 282:2340-2346. (Pubitemid 30013066)
5. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991;303:276-282.
6. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet. 1998;352:1801-1807.
7. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol); Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol). National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet. 2011;377:578-586.
8. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090-1101.
9. National Bureau of Statistics of China. China statistical yearbook, 2006. Beijing, China: China Statistics Press; 2006. http://www.stats.gov.cn/tjsj/ ndsj/2006/indexeh.htm. Accessed June 26, 2011.
10. Luepker RV, Evans A, McKeigue P, Reddy KS. Cardiovascular Survey Methods. 3rd ed. Geneva, Switzerland: World Health Organization; 2004.
11. National Bureau of Statistics of China. China statistical yearbook, 2008. Beijing, China: China Statistics Press; 2008. http://www.stats.gov.cn/tjsj/ ndsj/2008/indexeh.htm. Accessed June 26, 2011.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2496.
13. People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China: Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation. 1992;85:1083-1096.
14. Li YH, Li Y, Davis CE, Chen Z, Tao S, Folsom AR, Bachorik P, Stamler J, Abernathy JR. Serum cholesterol changes from 1983-1984 to 1993-1994 in the People's Republic of China. Nutr Metab Cardiovasc Dis. 2002;12:118-126. (Pubitemid 135712754)
15. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, Chen J, Liu D, Mo J, Whelton PK; InterASIA Collaborative Group. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation. 2004;110:405-411. (Pubitemid 38993849)
16. Wong LD, ed. The 2002 China National Nutrition and Health Survey (1): General Report. Beijing, China: People Health Publishing House; 2005.
17. Tao SC, Huang ZD, Wu XG, Zhou BF, Xiao ZK, Hao JS, Li YH, Cen RC, Rao XX. CHD and its risk factors in the People's Republic of China. Int J Epidemiol. 1989;18:S159-S163.
18. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: Impact of statin trials. Circulation. 1998;97:946-952. (Pubitemid 28125465)
19. Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol. 2001;30(suppl 1):S35-S40. (Pubitemid 33041210)
20. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005;294:1773-1781. (Pubitemid 41434623)
21. Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA. 2009; 302:2104-2110.
22. Jia WP, Xiang KS, Chen L, Lu JX, Wu YM. Epidemiological study on obesity and its co-morbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev. 2002;3:157-165. (Pubitemid 34815234)
23. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H. Prevalence and associated factors of dyslipidemia in the adult Chinese population. PLoS ONE. 2011;6:e17326.
24. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation. 2003;107:2185-2189. (Pubitemid 36547210)
25. Pearson TA. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease. Am J Cardiol. 2004;94:4F-8F. (Pubitemid 39425212)
26. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79. (Pubitemid 36026281)
27. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-184. (Pubitemid 30451774)
28. Aucott L, Gray D, Rothnie H, Thapa M, Waweru C. Effects of lifestyle interventions and long-term weight loss on lipid outcomes: A systematic review. Obes Rev. 2011;12:e412-e425.
29. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis. Am J Clin Nutr. 1999;69:632-646. (Pubitemid 29193386)
30. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's Strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613.